{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:07:54Z","timestamp":1761523674393},"reference-count":27,"publisher":"Baishideng Publishing Group Inc.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJCO"],"published-print":{"date-parts":[[2013]]},"DOI":"10.5306\/wjco.v4.i2.43","type":"journal-article","created":{"date-parts":[[2013,5,13]],"date-time":"2013-05-13T23:27:03Z","timestamp":1368487623000},"page":"43","source":"Crossref","is-referenced-by-count":13,"title":["Statin a day keeps cancer at bay"],"prefix":"10.5306","volume":"4","author":[{"given":"Siddharth","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM. Statins and cancer prevention. Nat Rev Cancer 2005;5:930-942.","DOI":"10.1038\/nrc1751"},{"key":"ref2","unstructured":"Chan KK, Oza AM, Siu LL. The statins as anticancer agents. Clin Cancer Res 2003;9:10-19."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046691"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.10.005"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt150"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.12.036"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.10.8936"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-012-2154-x"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029849"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1201735"},{"key":"ref11","unstructured":"Evans JS, Harries C, Dennis I, Dean J. General practitioners’ tacit and stated policies in the prescription of lipid lowering agents. Br J Gen Pract 1995;45:15-18."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021423"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2012.1397"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.138"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60209-8"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1313"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.71"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs318"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0462"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Singh PP, Singh S. Statins and risk reduction in hepatocellular carcinoma: fact or fiction? J Clin Oncol 2012;30:2569-270; author reply 2569-2570.","DOI":"10.1200\/JCO.2012.43.2179"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.5"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61720-0"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.289"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI13505"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1211024"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.3560"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.1.74"}],"container-title":["World Journal of Clinical Oncology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T15:28:52Z","timestamp":1563031732000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/2218-4333\/full\/v4\/i2\/43.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.5306\/wjco.v4.i2.43","relation":{},"ISSN":["2218-4333"],"issn-type":[{"value":"2218-4333","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}